Why the study?
How should aspirin and clopidogrel resistance be evaluated and managed?
How should aspirin and clopidogrel resistance be evaluated and managed?
The review highlights the lack of standardized methods to quantify antiplatelet resistance and suggests higher doses or strict compliance as potential management strategies.
Authors
No takes yet. Share an insight, caveat, or question.
Absence of uniform platelet reactivity assays precludes routine testing in practice; leaves open the need for validated methods and evidence-based dosing.
Gurbel et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: